Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99. Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Viewpoint Jan 2022 How Medical-Dental EHR Integration Can Improve Diabetes Care Neel Shimpi, BDS, MM, PhD, Elizabeth Buchanan, PhD, and Amit Acharya, BDS, MS, PhD Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General. AMA J Ethics. 2022;24(1):E99-105. doi: 10.1001/amajethics.2022.99.
Medicine and Society Feb 2021 Should Clinical Guidelines Incorporate Cost Pathways for Persons With Financial Hardship? David Goldberg, MD Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear. AMA J Ethics. 2021;23(2):E175-182. doi: 10.1001/amajethics.2021.175.